MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date

Monday, June 20, 2016

12:30pm-2:00pm
Progression of microglial activation and neuroinflammatory responses in a transgenic mouse model of multiple system atrophy

V. Refolo, S. Venezia, G.K. Wenning, M. Romero-Ramos, N. Stefanova (Innsbruck, Austria)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus)  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Progressive supranuclear palsy as a manifestation of the second stage of CADASIL syndrome

B. Muinjonov, E. Giyazitdinova, G. Rakhimbaeva (Tashkent, Uzbekistan)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus)  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Promoting optimal physiotherapy practice worldwide: Role of the Association of Physiotherapists in Parkinson’s disease Europe (APPDE)

M. Graziano, D. Jones, B. Ramaswamy, F. Lindop (Esch-sur-Alzette, Luxembourg)

Quality of life/caregiver burden in movement disorders  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
PROSPECT: A UK-based longitudinal observational study of PSP, CBD, MSA and atypical parkinsonism syndromes

J. Woodside, R. Lamb, V. Chelban, D. Burn, A. Church, A. Gerhard, M. Hu, N. Leigh, J. Rowe, H. Houlden (London, United Kingdom)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus)  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Prospective evaluation of pallidal deep brain stimulation in Huntington’s disease

S. Zittel, V. Tadic, C. Moll, A. Fellbrich, N. Brüggemann, D. Rasche, T. Bäumer, V. Tronnier, A. Münchau (Luebeck, Germany)

Surgical therapy: Other movement disorders  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Pshychoeducational interventions for demented patients with parkinsonism and their families

P.N.S. Almeida, A.C.P. Koutsandréou, A.C.M. Neri (Salvador, Brazil)

Education in movement disorders  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
PSP and HIV: Causality or coincidence?

L.A. Crespo Araico, P. Agüero Rabes, E. Viedma Guiard, P. Martinez Ulloa, C. Estévez Fraga, A. Alonso Cánovas, I. Corral Corral, L. Cabañes Martinez, E. Navas Elorza, J.C. Martinez Castrillo, I. Avilés Olmos (Madrid, Spain)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus)  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Pulmonary dysfunction in Parkinson’s disease: A feature of early disease?

G. Baille, T. Perez, D. Devos, L. Defebvre, C. Moreau (Lille, France)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson’s disease

H.S. Dafsari, L. Weiss, M. Silverdale, P. Reddy, A. Rizos, M. Samuel, E. Perrier, J. Evans, K. Ashkan, J.N. Petry-Schmelzer, V. Visser-Vandewalle, A. Antonini, P. Martinez-Martin, K.R. Chaudhuri, L. Timmermann (Cologne, Germany)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Quality of life and epidemiological profile of patients undergoing botulinum toxin treatment

G. Amorelli, L.F. Vasconcellos, M. Spitz, L.F. Fraga (Rio de Janeiro, Brazil)

Quality of life/caregiver burden in movement disorders  ·  Exhibit Hall located in Hall B, Level 2
  • «Previous Page
  • 1
  • …
  • 38
  • 39
  • 40
  • 41
  • 42
  • …
  • 53
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley